Current understanding of individual genetic characteristics is improving the ability to treat cardiovascular disorders.
Cardiovascular disease remains the number one cause of death in the United States and will likely become the number one cause of death globally.
Cardio Genetic Sequencing:
Genetic variations have been described in association with cardiomyopathies, arrhythmias, and many cardiac disorders. The genetic cause of these heart disorders can now be determined and can aid in diagnosis and provide valuable information about prognosis and treatment.
Arrhythmic Disorders Channelopathies
•Right Ventricle Cardiomyopathy
Coronary Vessel Disease
Aorta & Aortic Valve Disorders
Panels and Single Genes:
MyGenetx also offers additional genetic testing to help identify risks related to cardiovascular disease.
KIF6, 9P21, 4Q25, LPA
SINGLE GENE OPTIONS:
This is proprietary to MyGenetx and identifies those at increased risk of cardiovascular disease and is especially relevant to diabetics.
MTHFR, FACTOR II, FACTOR V
Identifies patients with unexplained DVT who would benefit from extended of lifelong anticoagulation.
PHARMACOGENETICS “The Right Patient. The Right Drug. The First Time”
•Clopidogrel CYP2C19 FDA BLACK BOX WARNING
•Beta Blockers CYP2D6
•Anticoagulant Panel VKORC1, CYP2C9
HEART SMART SCREEN A solution for dental professionals. Using a dry blood spot card collection method, dentists have the option of checking hs-CRP and A1C. A 2013 study in the American Heart Association's Circulation,states that half of heart attacks are caused by oral pathogens.